

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vitamin A metabolic process (GO:0006776) | 7.91846343 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.46689510 |
| 3 | regulation of protein activation cascade (GO:2000257) | 7.40329036 |
| 4 | complement activation, alternative pathway (GO:0006957) | 7.20395219 |
| 5 | regulation of complement activation (GO:0030449) | 7.04701794 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 7.03312941 |
| 7 | flavonoid metabolic process (GO:0009812) | 6.94097274 |
| 8 | protein carboxylation (GO:0018214) | 6.85632200 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.85632200 |
| 10 | regulation of fibrinolysis (GO:0051917) | 6.85300531 |
| 11 | adhesion of symbiont to host cell (GO:0044650) | 6.61984132 |
| 12 | virion attachment to host cell (GO:0019062) | 6.61984132 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.21496372 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 6.21496372 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20303529 |
| 16 | phospholipid efflux (GO:0033700) | 5.95617932 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.88957607 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 5.88957607 |
| 19 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.85385890 |
| 20 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.85385890 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 5.72691054 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 5.70390283 |
| 23 | digestive system process (GO:0022600) | 5.68473222 |
| 24 | actin filament depolymerization (GO:0030042) | 5.51616762 |
| 25 | plasma lipoprotein particle assembly (GO:0034377) | 5.48281009 |
| 26 | drug catabolic process (GO:0042737) | 5.43297074 |
| 27 | epoxygenase P450 pathway (GO:0019373) | 5.43269651 |
| 28 | glyoxylate metabolic process (GO:0046487) | 5.42578457 |
| 29 | blood coagulation, intrinsic pathway (GO:0007597) | 5.32899849 |
| 30 | adhesion of symbiont to host (GO:0044406) | 5.32776245 |
| 31 | regulation of plasminogen activation (GO:0010755) | 5.22186580 |
| 32 | protein-lipid complex assembly (GO:0065005) | 5.17820066 |
| 33 | low-density lipoprotein particle remodeling (GO:0034374) | 5.12399656 |
| 34 | modified amino acid transport (GO:0072337) | 4.99180056 |
| 35 | fibrinolysis (GO:0042730) | 4.83551538 |
| 36 | hormone catabolic process (GO:0042447) | 4.81235465 |
| 37 | lipoprotein metabolic process (GO:0042157) | 4.80575942 |
| 38 | cholesterol efflux (GO:0033344) | 4.77503075 |
| 39 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.73126066 |
| 40 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.73126066 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 4.64897914 |
| 42 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.64309396 |
| 43 | peptide catabolic process (GO:0043171) | 4.61550967 |
| 44 | digestion (GO:0007586) | 4.51828513 |
| 45 | phenylpropanoid metabolic process (GO:0009698) | 4.51520812 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.49719339 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.49719339 |
| 48 | diacylglycerol metabolic process (GO:0046339) | 4.49375962 |
| 49 | NADH metabolic process (GO:0006734) | 4.48780429 |
| 50 | negative regulation of protein activation cascade (GO:2000258) | 4.41587267 |
| 51 | acute-phase response (GO:0006953) | 4.41333152 |
| 52 | glucose 6-phosphate metabolic process (GO:0051156) | 4.40750275 |
| 53 | protein activation cascade (GO:0072376) | 4.39348896 |
| 54 | negative regulation of blood coagulation (GO:0030195) | 4.35156387 |
| 55 | negative regulation of hemostasis (GO:1900047) | 4.35156387 |
| 56 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.30299340 |
| 57 | purine nucleotide salvage (GO:0032261) | 4.28470213 |
| 58 | negative regulation of lipase activity (GO:0060192) | 4.28460601 |
| 59 | regulation of humoral immune response (GO:0002920) | 4.27937971 |
| 60 | proline metabolic process (GO:0006560) | 4.24594641 |
| 61 | drinking behavior (GO:0042756) | 4.21469246 |
| 62 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.18263912 |
| 63 | complement activation, classical pathway (GO:0006958) | 4.17666998 |
| 64 | bile acid metabolic process (GO:0008206) | 4.17114195 |
| 65 | peptide hormone processing (GO:0016486) | 4.11270659 |
| 66 | exogenous drug catabolic process (GO:0042738) | 4.08399256 |
| 67 | response to hepatocyte growth factor (GO:0035728) | 4.05794928 |
| 68 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.05794928 |
| 69 | regulation of apoptotic cell clearance (GO:2000425) | 4.02384521 |
| 70 | transepithelial transport (GO:0070633) | 4.01109227 |
| 71 | negative regulation of coagulation (GO:0050819) | 4.00803190 |
| 72 | negative regulation of sterol transport (GO:0032372) | 4.00362543 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 4.00362543 |
| 74 | reverse cholesterol transport (GO:0043691) | 3.98920914 |
| 75 | sterol transport (GO:0015918) | 3.98765045 |
| 76 | cholesterol transport (GO:0030301) | 3.98765045 |
| 77 | cholesterol homeostasis (GO:0042632) | 3.97983846 |
| 78 | negative regulation of wound healing (GO:0061045) | 3.96855562 |
| 79 | aromatic amino acid family catabolic process (GO:0009074) | 3.95151826 |
| 80 | regulation of bile acid biosynthetic process (GO:0070857) | 3.94908316 |
| 81 | sterol homeostasis (GO:0055092) | 3.94622454 |
| 82 | complement activation (GO:0006956) | 3.94340981 |
| 83 | ethanol oxidation (GO:0006069) | 3.91985285 |
| 84 | oligosaccharide catabolic process (GO:0009313) | 3.84469096 |
| 85 | lipoprotein transport (GO:0042953) | 3.83316911 |
| 86 | bile acid biosynthetic process (GO:0006699) | 3.79483613 |
| 87 | sulfation (GO:0051923) | 3.78124016 |
| 88 | serine family amino acid catabolic process (GO:0009071) | 3.75689970 |
| 89 | bile acid and bile salt transport (GO:0015721) | 3.74880173 |
| 90 | arginine metabolic process (GO:0006525) | 3.73823053 |
| 91 | omega-hydroxylase P450 pathway (GO:0097267) | 3.72835747 |
| 92 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.70607892 |
| 93 | response to hydroperoxide (GO:0033194) | 3.69050642 |
| 94 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.68309705 |
| 95 | intestinal epithelial cell development (GO:0060576) | 3.64836004 |
| 96 | positive regulation of steroid metabolic process (GO:0045940) | 3.63204215 |
| 97 | negative regulation of complement activation (GO:0045916) | 3.62136979 |
| 98 | positive regulation of blood coagulation (GO:0030194) | 3.62061792 |
| 99 | positive regulation of hemostasis (GO:1900048) | 3.62061792 |
| 100 | glutamate metabolic process (GO:0006536) | 3.62061481 |
| 101 | sulfate transmembrane transport (GO:1902358) | 3.60707119 |
| 102 | regulation of digestive system process (GO:0044058) | 3.54805447 |
| 103 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.53155258 |
| 104 | urea metabolic process (GO:0019627) | 3.52721104 |
| 105 | urea cycle (GO:0000050) | 3.52721104 |
| 106 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.51418564 |
| 107 | cytolysis (GO:0019835) | 3.50530783 |
| 108 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49510220 |
| 109 | acute inflammatory response (GO:0002526) | 3.49331650 |
| 110 | cytidine deamination (GO:0009972) | 3.47752751 |
| 111 | cytidine metabolic process (GO:0046087) | 3.47752751 |
| 112 | cytidine catabolic process (GO:0006216) | 3.47752751 |
| 113 | high-density lipoprotein particle remodeling (GO:0034375) | 3.45386447 |
| 114 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.42331765 |
| 115 | sulfur compound transport (GO:0072348) | 3.38904997 |
| 116 | oxidative demethylation (GO:0070989) | 3.37829661 |
| 117 | plasma lipoprotein particle organization (GO:0071827) | 3.37085840 |
| 118 | regulation of lipoprotein particle clearance (GO:0010984) | 3.36707546 |
| 119 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.35111654 |
| 120 | lipid homeostasis (GO:0055088) | 3.34624241 |
| 121 | protein-lipid complex remodeling (GO:0034368) | 3.33643815 |
| 122 | macromolecular complex remodeling (GO:0034367) | 3.33643815 |
| 123 | plasma lipoprotein particle remodeling (GO:0034369) | 3.33643815 |
| 124 | protein-lipid complex subunit organization (GO:0071825) | 3.33024336 |
| 125 | innate immune response in mucosa (GO:0002227) | 3.32934883 |
| 126 | bicarbonate transport (GO:0015701) | 3.32135281 |
| 127 | sperm capacitation (GO:0048240) | 3.31374478 |
| 128 | polyol transport (GO:0015791) | 3.29267760 |
| 129 | negative regulation of digestive system process (GO:0060457) | 3.28703239 |
| 130 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.28102836 |
| 131 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.27823949 |
| 132 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.27823949 |
| 133 | endocrine process (GO:0050886) | 3.27823949 |
| 134 | response to phenylpropanoid (GO:0080184) | 3.27384783 |
| 135 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.27017373 |
| 136 | cellular glucuronidation (GO:0052695) | 3.25922555 |
| 137 | drug metabolic process (GO:0017144) | 3.25668818 |
| 138 | sphingomyelin metabolic process (GO:0006684) | 3.24288983 |
| 139 | regulation of lipoprotein metabolic process (GO:0050746) | 3.22243193 |
| 140 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.20816271 |
| 141 | regulation of cholesterol homeostasis (GO:2000188) | 3.19559042 |
| 142 | drug transport (GO:0015893) | 3.18241952 |
| 143 | nitrogen cycle metabolic process (GO:0071941) | 3.16685801 |
| 144 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.16204892 |
| 145 | thyroid hormone metabolic process (GO:0042403) | 3.15250783 |
| 146 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.11089498 |
| 147 | regulation of cellular extravasation (GO:0002691) | 3.07486041 |
| 148 | cellular carbohydrate catabolic process (GO:0044275) | 3.07224117 |
| 149 | fructose metabolic process (GO:0006000) | 3.06503423 |
| 150 | uronic acid metabolic process (GO:0006063) | 3.06270446 |
| 151 | glucuronate metabolic process (GO:0019585) | 3.06270446 |
| 152 | positive regulation of lipid catabolic process (GO:0050996) | 3.05051701 |
| 153 | intestinal absorption (GO:0050892) | 13.0711356 |
| 154 | intestinal cholesterol absorption (GO:0030299) | 11.8226157 |
| 155 | angiotensin maturation (GO:0002003) | 11.1399323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.87747482 |
| 2 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.20538020 |
| 3 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.91659462 |
| 4 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.88873188 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.42843604 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.41177447 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.36213153 |
| 8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.02731807 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.01654905 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.91382820 |
| 11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.68138517 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.66003804 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.65374247 |
| 14 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.64969323 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47980180 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39746296 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15779652 |
| 18 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.04550049 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.1373880 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95070544 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94815317 |
| 22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.85757629 |
| 23 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.85101568 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.81410138 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80843821 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.78303961 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77614178 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74245983 |
| 29 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.67968359 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65162647 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54303633 |
| 32 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.51756865 |
| 33 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50994288 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50882236 |
| 35 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.48744554 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48454077 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48401637 |
| 38 | ATF3_27146783_Chip-Seq_COLON_Human | 1.46977905 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45783074 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44440014 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42397212 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40629506 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40352309 |
| 44 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.38651393 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38183740 |
| 46 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37110983 |
| 47 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34392545 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32551600 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31255066 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30201391 |
| 51 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28497891 |
| 52 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25293348 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24984129 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24500619 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24145337 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23341078 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21725237 |
| 58 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.19943077 |
| 59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19830822 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.19184771 |
| 61 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15228896 |
| 62 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14538021 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14409683 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11894075 |
| 65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10361444 |
| 66 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10093315 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09953103 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09922963 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09591603 |
| 70 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09337621 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08997667 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07814785 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06135040 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05707411 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04692393 |
| 76 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.04085575 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03115429 |
| 78 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01795658 |
| 79 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01128588 |
| 80 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99811592 |
| 81 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97092986 |
| 82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95561047 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94691211 |
| 84 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94544547 |
| 85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94169368 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94077514 |
| 87 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.93444174 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92476285 |
| 89 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.90842494 |
| 90 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90813715 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90621445 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88058074 |
| 93 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87838170 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87291196 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87227468 |
| 96 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86170998 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86170553 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86154139 |
| 99 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85734045 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85051061 |
| 101 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84632749 |
| 102 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.83001008 |
| 103 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82278623 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82202167 |
| 105 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.82039952 |
| 106 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81848752 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81705205 |
| 108 | SA1_27219007_Chip-Seq_Bcells_Human | 0.81608330 |
| 109 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.81502777 |
| 110 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80632678 |
| 111 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.79850949 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79207520 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79050836 |
| 114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78818040 |
| 115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78595914 |
| 116 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78595914 |
| 117 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.78542395 |
| 118 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.78530524 |
| 119 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78020024 |
| 120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76724287 |
| 121 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.76582859 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76144061 |
| 123 | P68_20966046_ChIP-Seq_HELA_Human | 0.75690419 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75658623 |
| 125 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75509328 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.75373779 |
| 127 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.75292619 |
| 128 | P300_27268052_Chip-Seq_Bcells_Human | 0.75117268 |
| 129 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75013267 |
| 130 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74432469 |
| 131 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.74216893 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73595741 |
| 133 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.72662672 |
| 134 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.71580935 |
| 135 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70078943 |
| 136 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.69355447 |
| 137 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68788891 |
| 138 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.67702892 |
| 139 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.67304861 |
| 140 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.66367636 |
| 141 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64846341 |
| 142 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.64771047 |
| 143 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.64238221 |
| 144 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.63995346 |
| 145 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.63478980 |
| 146 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.62701399 |
| 147 | ERA_21632823_ChIP-Seq_H3396_Human | 0.59968059 |
| 148 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.59910586 |
| 149 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.58940986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.72698132 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.93680088 |
| 3 | MP0009840_abnormal_foam_cell | 4.44564544 |
| 4 | MP0003195_calcinosis | 4.37210748 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.90153542 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.76621358 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.60425985 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.57260053 |
| 9 | MP0003868_abnormal_feces_composition | 3.35209057 |
| 10 | MP0000462_abnormal_digestive_system | 3.16964806 |
| 11 | MP0003252_abnormal_bile_duct | 2.97074498 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.93862713 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.72098555 |
| 14 | MP0003866_abnormal_defecation | 2.64403731 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.58147657 |
| 16 | MP0002254_reproductive_system_inflammat | 2.40618468 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.36557807 |
| 18 | MP0001873_stomach_inflammation | 2.31705757 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.21760197 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.00192664 |
| 21 | MP0001663_abnormal_digestive_system | 1.99797219 |
| 22 | MP0005381_digestive/alimentary_phenotyp | 1.88967772 |
| 23 | MP0000537_abnormal_urethra_morphology | 1.86116651 |
| 24 | MP0000490_abnormal_crypts_of | 1.84902072 |
| 25 | MP0009379_abnormal_foot_pigmentation | 1.83866559 |
| 26 | MP0005084_abnormal_gallbladder_morpholo | 1.74285312 |
| 27 | MP0004147_increased_porphyrin_level | 1.73013191 |
| 28 | MP0002822_catalepsy | 1.72317446 |
| 29 | MP0001664_abnormal_digestion | 1.69389003 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.66258116 |
| 31 | MP0000477_abnormal_intestine_morphology | 1.58923522 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.58285612 |
| 33 | MP0009697_abnormal_copulation | 1.56867182 |
| 34 | MP0004043_abnormal_pH_regulation | 1.53244210 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.50533726 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.49948536 |
| 37 | MP0003878_abnormal_ear_physiology | 1.49948536 |
| 38 | MP0005408_hypopigmentation | 1.49913710 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.43098578 |
| 40 | MP0003122_maternal_imprinting | 1.41875648 |
| 41 | MP0005448_abnormal_energy_balance | 1.39300748 |
| 42 | MP0002796_impaired_skin_barrier | 1.34090864 |
| 43 | MP0005332_abnormal_amino_acid | 1.29143201 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.28874596 |
| 45 | MP0005365_abnormal_bile_salt | 1.26385674 |
| 46 | MP0002089_abnormal_postnatal_growth/wei | 1.23984713 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.20603285 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.18593393 |
| 49 | MP0000566_synostosis | 1.18286580 |
| 50 | MP0003718_maternal_effect | 1.15020702 |
| 51 | MP0008004_abnormal_stomach_pH | 1.09956216 |
| 52 | MP0008872_abnormal_physiological_respon | 1.07597440 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.05169833 |
| 54 | MP0006054_spinal_hemorrhage | 1.03405077 |
| 55 | MP0000598_abnormal_liver_morphology | 1.02081437 |
| 56 | MP0005409_darkened_coat_color | 0.97406103 |
| 57 | MP0000609_abnormal_liver_physiology | 0.93968262 |
| 58 | MP0002132_abnormal_respiratory_system | 0.93889485 |
| 59 | MP0001915_intracranial_hemorrhage | 0.92712217 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.92485647 |
| 61 | MP0005670_abnormal_white_adipose | 0.91493492 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 0.90699856 |
| 63 | MP0005464_abnormal_platelet_physiology | 0.87949489 |
| 64 | MP0005266_abnormal_metabolism | 0.85539079 |
| 65 | MP0003172_abnormal_lysosome_physiology | 0.84900928 |
| 66 | MP0004947_skin_inflammation | 0.84351410 |
| 67 | MP0002098_abnormal_vibrissa_morphology | 0.81209147 |
| 68 | MP0001849_ear_inflammation | 0.79496441 |
| 69 | MP0002971_abnormal_brown_adipose | 0.79092471 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.76875213 |
| 71 | MP0003123_paternal_imprinting | 0.76815011 |
| 72 | MP0005501_abnormal_skin_physiology | 0.76400168 |
| 73 | MP0001661_extended_life_span | 0.75269874 |
| 74 | MP0001764_abnormal_homeostasis | 0.74730087 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 0.73814655 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.72947583 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.71608711 |
| 78 | MP0000470_abnormal_stomach_morphology | 0.70607090 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.69931527 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.68839778 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.68652234 |
| 82 | MP0005367_renal/urinary_system_phenotyp | 0.68643088 |
| 83 | MP0000516_abnormal_urinary_system | 0.68643088 |
| 84 | MP0005310_abnormal_salivary_gland | 0.67786312 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.65745747 |
| 86 | MP0003283_abnormal_digestive_organ | 0.65661078 |
| 87 | MP0000678_abnormal_parathyroid_gland | 0.65250599 |
| 88 | MP0001756_abnormal_urination | 0.64819180 |
| 89 | MP0010678_abnormal_skin_adnexa | 0.64240210 |
| 90 | MP0005395_other_phenotype | 0.63526108 |
| 91 | MP0005166_decreased_susceptibility_to | 0.61202278 |
| 92 | MP0003315_abnormal_perineum_morphology | 0.60683977 |
| 93 | MP0009053_abnormal_anal_canal | 0.60601427 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.60062120 |
| 95 | MP0009333_abnormal_splenocyte_physiolog | 0.59689561 |
| 96 | MP0005451_abnormal_body_composition | 0.59258178 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.58380976 |
| 98 | MP0000249_abnormal_blood_vessel | 0.58188758 |
| 99 | MP0004270_analgesia | 0.56314715 |
| 100 | MP0003879_abnormal_hair_cell | 0.55862826 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.55185516 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.54937884 |
| 103 | MP0000613_abnormal_salivary_gland | 0.54598009 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.54050127 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.53862447 |
| 106 | MP0002148_abnormal_hypersensitivity_rea | 0.53805411 |
| 107 | MP0005083_abnormal_biliary_tract | 0.53107131 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.51693236 |
| 109 | MP0003186_abnormal_redox_activity | 0.51494526 |
| 110 | MP0009763_increased_sensitivity_to | 0.51306930 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.51099893 |
| 112 | MP0003953_abnormal_hormone_level | 0.50376346 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.49480486 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.48536917 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48191890 |
| 116 | MP0003119_abnormal_digestive_system | 0.48011831 |
| 117 | MP0003941_abnormal_skin_development | 0.47961962 |
| 118 | MP0003329_amyloid_beta_deposits | 0.46321600 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.46229143 |
| 120 | MP0001881_abnormal_mammary_gland | 0.45835424 |
| 121 | MP0004272_abnormal_basement_membrane | 0.44741034 |
| 122 | MP0009115_abnormal_fat_cell | 0.44722740 |
| 123 | MP0003011_delayed_dark_adaptation | 0.44186398 |
| 124 | MP0001191_abnormal_skin_condition | 0.43758599 |
| 125 | MP0005164_abnormal_response_to | 0.43592446 |
| 126 | MP0005535_abnormal_body_temperature | 0.42937140 |
| 127 | MP0008469_abnormal_protein_level | 0.42438766 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.41879828 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.40870597 |
| 130 | MP0005334_abnormal_fat_pad | 0.39018276 |
| 131 | MP0000639_abnormal_adrenal_gland | 0.38973860 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.38472468 |
| 133 | MP0000604_amyloidosis | 0.37718902 |
| 134 | MP0005410_abnormal_fertilization | 0.36930391 |
| 135 | MP0005257_abnormal_intraocular_pressure | 0.36780705 |
| 136 | MP0002970_abnormal_white_adipose | 0.36627481 |
| 137 | MP0009764_decreased_sensitivity_to | 0.34613338 |
| 138 | MP0002909_abnormal_adrenal_gland | 0.33929260 |
| 139 | MP0005187_abnormal_penis_morphology | 0.31270840 |
| 140 | MP0002168_other_aberrant_phenotype | 0.30422659 |
| 141 | MP0003567_abnormal_fetal_cardiomyocyte | 0.30166732 |
| 142 | MP0004883_abnormal_blood_vessel | 0.29563257 |
| 143 | MP0002090_abnormal_vision | 0.29395039 |
| 144 | MP0000920_abnormal_myelination | 0.29122974 |
| 145 | MP0008260_abnormal_autophagy | 0.29121459 |
| 146 | MP0005220_abnormal_exocrine_pancreas | 0.28932354 |
| 147 | MP0003690_abnormal_glial_cell | 0.28242173 |
| 148 | MP0005023_abnormal_wound_healing | 0.27571972 |
| 149 | MP0009780_abnormal_chondrocyte_physiolo | 0.27429879 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.27325255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 8.40837135 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 7.76838339 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.21794010 |
| 4 | Complement deficiency (HP:0004431) | 6.97066254 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.88153688 |
| 6 | Acanthocytosis (HP:0001927) | 6.62673558 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 6.32303132 |
| 8 | Joint hemorrhage (HP:0005261) | 6.17062040 |
| 9 | Malnutrition (HP:0004395) | 6.02899816 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.00230902 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 5.87665601 |
| 12 | Abnormality of complement system (HP:0005339) | 5.49327063 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 5.43829780 |
| 14 | Hydroxyprolinuria (HP:0003080) | 5.43829780 |
| 15 | Glomerulonephritis (HP:0000099) | 5.18131972 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.92020106 |
| 17 | Autoimmune hemolytic anemia (HP:0001890) | 4.70829388 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 4.56669598 |
| 19 | Spontaneous abortion (HP:0005268) | 4.37226081 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 4.34510166 |
| 21 | Cupped ribs (HP:0000887) | 4.26820309 |
| 22 | Pigmentary retinal degeneration (HP:0001146) | 4.12034597 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 4.09499693 |
| 24 | Widely patent fontanelles and sutures (HP:0004492) | 3.91119188 |
| 25 | Abnormality of urine glucose concentration (HP:0011016) | 3.87431270 |
| 26 | Glycosuria (HP:0003076) | 3.87431270 |
| 27 | Poikilocytosis (HP:0004447) | 3.86953321 |
| 28 | Hemorrhage of the eye (HP:0011885) | 3.80297742 |
| 29 | Increased IgE level (HP:0003212) | 3.73910997 |
| 30 | Fat malabsorption (HP:0002630) | 3.73298638 |
| 31 | Hypolipoproteinemia (HP:0010981) | 3.70326735 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69857727 |
| 33 | Mesangial abnormality (HP:0001966) | 3.61476300 |
| 34 | Hyperglycinuria (HP:0003108) | 3.58768998 |
| 35 | Abdominal distention (HP:0003270) | 3.45778967 |
| 36 | Menorrhagia (HP:0000132) | 3.33600159 |
| 37 | Gingival bleeding (HP:0000225) | 3.25467412 |
| 38 | Chronic diarrhea (HP:0002028) | 3.23790726 |
| 39 | Severe combined immunodeficiency (HP:0004430) | 3.19101130 |
| 40 | Facial shape deformation (HP:0011334) | 3.17978749 |
| 41 | Potter facies (HP:0002009) | 3.17978749 |
| 42 | Nephritis (HP:0000123) | 3.16309578 |
| 43 | Vascular calcification (HP:0004934) | 3.14269750 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 3.11676358 |
| 45 | Abnormality of B cell number (HP:0010975) | 3.10767927 |
| 46 | B lymphocytopenia (HP:0010976) | 3.10767927 |
| 47 | Combined immunodeficiency (HP:0005387) | 3.04651542 |
| 48 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.94651366 |
| 49 | Gastrointestinal dysmotility (HP:0002579) | 2.93841698 |
| 50 | Hyperphosphaturia (HP:0003109) | 2.93760702 |
| 51 | Purpura (HP:0000979) | 2.91457119 |
| 52 | Congenital sensorineural hearing impairment (HP:0008527) | 2.91030484 |
| 53 | Hyperglycinemia (HP:0002154) | 2.80950816 |
| 54 | Wide cranial sutures (HP:0010537) | 2.80589357 |
| 55 | Dehydration (HP:0001944) | 2.77864669 |
| 56 | Villous atrophy (HP:0011473) | 2.76511487 |
| 57 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.76511487 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.74877238 |
| 59 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74204894 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.73424837 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.72834624 |
| 62 | Abnormality of vitamin B metabolism (HP:0004340) | 2.71174544 |
| 63 | Nausea (HP:0002018) | 2.70206405 |
| 64 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.68407239 |
| 65 | Nephrolithiasis (HP:0000787) | 2.67991125 |
| 66 | Xanthomatosis (HP:0000991) | 2.67769284 |
| 67 | Reticulocytosis (HP:0001923) | 2.65424630 |
| 68 | Rectal prolapse (HP:0002035) | 2.63849377 |
| 69 | Abnormal glucose tolerance (HP:0001952) | 2.62770576 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.61347543 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.60615038 |
| 72 | Hypercholesterolemia (HP:0003124) | 2.56202410 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53501614 |
| 74 | Increased mean platelet volume (HP:0011877) | 2.52230680 |
| 75 | Gout (HP:0001997) | 2.49918983 |
| 76 | Mitral stenosis (HP:0001718) | 2.48235045 |
| 77 | Thyroiditis (HP:0100646) | 2.47960805 |
| 78 | Proximal tubulopathy (HP:0000114) | 2.46340503 |
| 79 | Steatorrhea (HP:0002570) | 2.46145738 |
| 80 | Abnormal urine phosphate concentration (HP:0012599) | 2.44376096 |
| 81 | Delayed CNS myelination (HP:0002188) | 2.44192495 |
| 82 | Abnormality of the gastric mucosa (HP:0004295) | 2.44017188 |
| 83 | Abnormality of the Achilles tendon (HP:0005109) | 2.42866344 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42782835 |
| 85 | Thrombophlebitis (HP:0004418) | 2.42559961 |
| 86 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.40899602 |
| 87 | Abnormality of glycine metabolism (HP:0010895) | 2.40899602 |
| 88 | Palpitations (HP:0001962) | 2.38758360 |
| 89 | Hypophosphatemic rickets (HP:0004912) | 2.38149794 |
| 90 | Osteomalacia (HP:0002749) | 2.37340162 |
| 91 | Pustule (HP:0200039) | 2.36461060 |
| 92 | Rickets (HP:0002748) | 2.33769585 |
| 93 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.33479104 |
| 94 | Cheilitis (HP:0100825) | 2.30855525 |
| 95 | Abnormality of vitamin metabolism (HP:0100508) | 2.30813455 |
| 96 | Enlarged kidneys (HP:0000105) | 2.29737974 |
| 97 | Abnormality of carpal bone ossification (HP:0006257) | 2.26573273 |
| 98 | Abnormal biliary tract morphology (HP:0012440) | 2.26137999 |
| 99 | Thin bony cortex (HP:0002753) | 2.24673110 |
| 100 | Abnormal tarsal ossification (HP:0008369) | 2.23219423 |
| 101 | Metabolic acidosis (HP:0001942) | 2.23173051 |
| 102 | Woolly hair (HP:0002224) | 2.20020631 |
| 103 | Confusion (HP:0001289) | 2.19642514 |
| 104 | Hyperammonemia (HP:0001987) | 2.18665779 |
| 105 | Pili torti (HP:0003777) | 2.17803440 |
| 106 | Abnormality of nucleobase metabolism (HP:0010932) | 2.16434991 |
| 107 | Abnormal platelet volume (HP:0011876) | 2.16013901 |
| 108 | Hyperparathyroidism (HP:0000843) | 2.14727883 |
| 109 | Syncope (HP:0001279) | 2.12136682 |
| 110 | Late onset (HP:0003584) | 2.11657757 |
| 111 | Intrahepatic cholestasis (HP:0001406) | 2.11602748 |
| 112 | Polycythemia (HP:0001901) | 2.10921414 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 2.09325190 |
| 114 | Arthropathy (HP:0003040) | 2.08637405 |
| 115 | Reduced antithrombin III activity (HP:0001976) | 2.06334617 |
| 116 | Retinal atrophy (HP:0001105) | 2.05432584 |
| 117 | Myocardial infarction (HP:0001658) | 2.04409486 |
| 118 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04167856 |
| 119 | Megaloblastic anemia (HP:0001889) | 2.04000071 |
| 120 | Deep venous thrombosis (HP:0002625) | 10.1002363 |
| 121 | Amyloidosis (HP:0011034) | 1.98121697 |
| 122 | Pulmonary embolism (HP:0002204) | 1.97270166 |
| 123 | Skin nodule (HP:0200036) | 1.96840433 |
| 124 | Abnormality of eosinophils (HP:0001879) | 1.95649335 |
| 125 | Symptomatic seizures (HP:0011145) | 1.95338882 |
| 126 | Eosinophilia (HP:0001880) | 1.95154139 |
| 127 | Hypoalbuminemia (HP:0003073) | 1.94506599 |
| 128 | Abnormal albumin level (HP:0012116) | 1.94506599 |
| 129 | Epidermoid cyst (HP:0200040) | 1.93598465 |
| 130 | Hypophosphatemia (HP:0002148) | 1.92103457 |
| 131 | Abnormality of reticulocytes (HP:0004312) | 1.91534283 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.87261948 |
| 133 | Cholecystitis (HP:0001082) | 1.87261948 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.85911767 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85911767 |
| 136 | Hypoglycemic coma (HP:0001325) | 1.85391630 |
| 137 | Increased serum pyruvate (HP:0003542) | 1.84999212 |
| 138 | Granulocytopenia (HP:0001913) | 1.83958558 |
| 139 | Abnormality of chloride homeostasis (HP:0011422) | 1.82177655 |
| 140 | Flat acetabular roof (HP:0003180) | 1.81869506 |
| 141 | Gingivitis (HP:0000230) | 1.81167609 |
| 142 | Joint swelling (HP:0001386) | 1.80462698 |
| 143 | Increased serum ferritin (HP:0003281) | 1.80192960 |
| 144 | Myopathic facies (HP:0002058) | 1.80159774 |
| 145 | Hyperuricemia (HP:0002149) | 1.80013628 |
| 146 | Increased purine levels (HP:0004368) | 1.80013628 |
| 147 | Delayed epiphyseal ossification (HP:0002663) | 1.79816287 |
| 148 | Irritability (HP:0000737) | 1.79329863 |
| 149 | Alkalosis (HP:0001948) | 1.79014664 |
| 150 | Hyperbilirubinemia (HP:0002904) | 1.76346380 |
| 151 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.75012139 |
| 152 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74629416 |
| 153 | Posterior subcapsular cataract (HP:0007787) | 1.73873715 |
| 154 | Ketoacidosis (HP:0001993) | 1.73573000 |
| 155 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72877827 |
| 156 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70362575 |
| 157 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70362575 |
| 158 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70362575 |
| 159 | Polygenic inheritance (HP:0010982) | 1.69290727 |
| 160 | Micronodular cirrhosis (HP:0001413) | 1.68336603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 5.45365101 |
| 2 | MST4 | 5.26842867 |
| 3 | FRK | 5.18900749 |
| 4 | MST1R | 4.28229677 |
| 5 | NME1 | 4.02764680 |
| 6 | PRKG2 | 3.62403529 |
| 7 | GRK6 | 3.59236303 |
| 8 | FGFR3 | 3.49137586 |
| 9 | MAP2K2 | 2.85098700 |
| 10 | NTRK3 | 2.71826699 |
| 11 | AKT3 | 2.28549622 |
| 12 | ACVR1B | 2.26526954 |
| 13 | EPHA2 | 2.25215458 |
| 14 | MAP3K10 | 2.23272260 |
| 15 | MAP3K2 | 2.21667892 |
| 16 | NUAK1 | 2.09103902 |
| 17 | TRIB3 | 2.04472430 |
| 18 | RIPK1 | 2.03847114 |
| 19 | PTK6 | 2.03652106 |
| 20 | PIK3CA | 1.98762064 |
| 21 | SIK1 | 1.95592354 |
| 22 | EPHB2 | 1.70184203 |
| 23 | ERN1 | 1.68333873 |
| 24 | PBK | 1.67543999 |
| 25 | MAP2K6 | 1.65996176 |
| 26 | TESK1 | 1.53855977 |
| 27 | PDGFRA | 1.47390852 |
| 28 | TESK2 | 1.42665479 |
| 29 | MET | 1.37124064 |
| 30 | MAP3K11 | 1.33428956 |
| 31 | EPHA4 | 1.27854918 |
| 32 | TYRO3 | 1.26793054 |
| 33 | MAP3K8 | 1.25729688 |
| 34 | STK10 | 1.25004985 |
| 35 | PRKCI | 1.22746235 |
| 36 | FGFR2 | 1.21375467 |
| 37 | PIK3CG | 1.21190920 |
| 38 | PIM2 | 1.20499103 |
| 39 | TTK | 1.19059012 |
| 40 | FGFR1 | 1.17973322 |
| 41 | TAOK1 | 1.11020908 |
| 42 | PDK1 | 1.08970407 |
| 43 | KSR2 | 1.04535788 |
| 44 | TBK1 | 1.00603364 |
| 45 | BCKDK | 0.99756855 |
| 46 | BMX | 0.98544880 |
| 47 | TYK2 | 0.96002593 |
| 48 | IRAK3 | 0.95698029 |
| 49 | EPHB1 | 0.93043541 |
| 50 | SCYL2 | 0.87826987 |
| 51 | PAK4 | 0.87212686 |
| 52 | PTK2 | 0.85921825 |
| 53 | RET | 0.85028656 |
| 54 | MATK | 0.84544517 |
| 55 | PRKCG | 0.82354308 |
| 56 | SIK2 | 0.81253661 |
| 57 | TAOK3 | 0.80663805 |
| 58 | CDC42BPA | 0.79105352 |
| 59 | DDR2 | 0.75522242 |
| 60 | ERBB2 | 0.75266296 |
| 61 | MAP4K1 | 0.74862958 |
| 62 | RIPK4 | 0.72626196 |
| 63 | TGFBR2 | 0.72227064 |
| 64 | FER | 0.71435448 |
| 65 | PRKAA2 | 0.70796458 |
| 66 | MAP3K1 | 0.70729596 |
| 67 | LRRK2 | 0.68747780 |
| 68 | MAP3K3 | 0.68379921 |
| 69 | PRKCZ | 0.64898792 |
| 70 | MAP3K14 | 0.61878608 |
| 71 | MAP2K1 | 0.61747074 |
| 72 | MYLK | 0.60319894 |
| 73 | MAPKAPK3 | 0.60293954 |
| 74 | CSF1R | 0.59214205 |
| 75 | MAPK11 | 0.58943226 |
| 76 | DYRK1B | 0.58762297 |
| 77 | ABL2 | 0.57484455 |
| 78 | BLK | 0.57313277 |
| 79 | STK39 | 0.56203893 |
| 80 | ERBB4 | 0.55035539 |
| 81 | WNK1 | 0.51985977 |
| 82 | SGK494 | 0.51530072 |
| 83 | SGK223 | 0.51530072 |
| 84 | MUSK | 0.51298595 |
| 85 | IGF1R | 0.50921868 |
| 86 | LATS1 | 0.50226426 |
| 87 | CSNK1E | 0.48716740 |
| 88 | SGK1 | 0.48438393 |
| 89 | ARAF | 0.46373846 |
| 90 | PRKG1 | 0.46274767 |
| 91 | FGFR4 | 0.46180243 |
| 92 | MAP3K9 | 0.45633584 |
| 93 | PAK1 | 0.45414662 |
| 94 | FGR | 0.44653445 |
| 95 | MAP2K3 | 0.44447282 |
| 96 | MAP3K7 | 0.43968584 |
| 97 | PRKACA | 0.43589251 |
| 98 | FLT3 | 0.43587134 |
| 99 | PKN2 | 0.43107067 |
| 100 | AURKB | 0.42086858 |
| 101 | MAP2K4 | 0.41527882 |
| 102 | NME2 | 0.41209549 |
| 103 | ZAP70 | 0.40620317 |
| 104 | CSNK1D | 0.40275197 |
| 105 | GRK1 | 0.38362145 |
| 106 | NLK | 0.37713662 |
| 107 | CDK12 | 0.37583040 |
| 108 | WNK4 | 0.37110152 |
| 109 | CSNK2A2 | 0.36362810 |
| 110 | PRKCB | 0.36203818 |
| 111 | MAP3K12 | 0.35563778 |
| 112 | NEK9 | 0.35534097 |
| 113 | SMG1 | 0.35238561 |
| 114 | NEK1 | 0.34351809 |
| 115 | PRKCD | 0.33982346 |
| 116 | EEF2K | 0.33025393 |
| 117 | CSNK2A1 | 0.32616923 |
| 118 | CDK6 | 0.32461839 |
| 119 | CSK | 0.32374606 |
| 120 | PDPK1 | 0.30287571 |
| 121 | RPS6KB1 | 0.29902230 |
| 122 | PRKCA | 0.29316215 |
| 123 | PRKCQ | 0.28885044 |
| 124 | MAPKAPK2 | 0.28228645 |
| 125 | IKBKE | 0.27579779 |
| 126 | EIF2AK1 | 0.27543819 |
| 127 | MAP3K6 | 0.26341863 |
| 128 | MAPK3 | 0.25962367 |
| 129 | CAMK2G | 0.25605241 |
| 130 | ICK | 0.25265515 |
| 131 | RPS6KA3 | 0.25058469 |
| 132 | PRKAA1 | 0.24412727 |
| 133 | SRC | 0.24147444 |
| 134 | CSNK1A1 | 0.23606351 |
| 135 | LIMK1 | 0.23356302 |
| 136 | CHUK | 0.22656377 |
| 137 | CDK4 | 0.21037184 |
| 138 | PRKACG | 0.20711132 |
| 139 | AKT2 | 0.20703633 |
| 140 | BRAF | 0.20311978 |
| 141 | JAK2 | 0.19583345 |
| 142 | MELK | 0.19541611 |
| 143 | GSK3A | 0.18879376 |
| 144 | IRAK4 | 0.18818532 |
| 145 | MAP3K13 | 0.18776474 |
| 146 | PDK2 | 0.18581397 |
| 147 | CDK7 | 0.16437574 |
| 148 | OXSR1 | 0.14927141 |
| 149 | PAK3 | 0.14251499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.16462716 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.61205343 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.37062360 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.30020152 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.19920871 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 3.95446136 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40036176 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.20274361 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.88200090 |
| 10 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.73496795 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.63157308 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63008724 |
| 13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.61681745 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.47067386 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43213522 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.25953810 |
| 17 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.20717005 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.16758939 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97466136 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83340518 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82154036 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.79623820 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.77837134 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.76250646 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.73649258 |
| 26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.66451295 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55013254 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44522353 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40102549 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37321707 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36541509 |
| 32 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36272427 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32898086 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27315685 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21262838 |
| 36 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20801223 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18077370 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15407422 |
| 39 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14602367 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14320296 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13702250 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12830178 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10483247 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.10313420 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08617525 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08373019 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.07756506 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05617696 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97152149 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96704347 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95581646 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95073262 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94786322 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93476040 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87205165 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85121606 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83483410 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82841208 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78215624 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74807172 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.71595330 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70305718 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69017530 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.64270122 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59932283 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58796992 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57626236 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55428929 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54090652 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53979158 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.50055307 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47975979 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40562907 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38021026 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37391753 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.36660464 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33843277 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33188807 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.33065324 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32875327 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32756126 |
| 82 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30604819 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30210304 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28974163 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.28160596 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27601640 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27196266 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26849225 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26839645 |
| 90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26422271 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26354730 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.25670839 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23277887 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23223806 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.22773185 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22611900 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.22291176 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.22087155 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.21271957 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20417730 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20281129 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.20004186 |
| 103 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.19165821 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16190721 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.16070498 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.15193055 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.13717898 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.11834493 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.11404632 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.11254639 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.09900511 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.07022450 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04690084 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.04384468 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.02664729 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.02534628 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.01735000 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.01654510 |
| 119 | Lysosome_Homo sapiens_hsa04142 | -0.1054458 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0836982 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0778132 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | -0.0682075 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0517706 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0384781 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0364582 |
| 126 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0357005 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0223243 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0126592 |
| 129 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0094044 |
| 130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | -0.0092691 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0020102 |

